Prof. Athanasia Printza
Medical School, Aristotle University of Thessaloniki, Thessaloníki, Kentrikí Makedonía, Greece
'%3e%3cpath%20d='M22.1642%2019.0924C21.7317%2018.068%2021.1041%2017.1375%2020.3163%2016.3527C19.5309%2015.5656%2018.6006%2014.9381%2017.5766%2014.5048C17.5674%2014.5002%2017.5582%2014.4979%2017.5491%2014.4933C18.9774%2013.4616%2019.9059%2011.7811%2019.9059%209.88504C19.9059%206.74408%2017.3611%204.19922%2014.2201%204.19922C11.0792%204.19922%208.53429%206.74408%208.53429%209.88504C8.53429%2011.7811%209.46282%2013.4616%2010.8912%2014.4956C10.882%2014.5002%2010.8728%2014.5025%2010.8636%2014.5071C9.83652%2014.9404%208.91487%2015.5617%208.1239%2016.355C7.33685%2017.1404%206.70933%2018.0707%206.276%2019.0947C5.85031%2020.0972%205.62072%2021.172%205.59967%2022.2609C5.59905%2022.2853%205.60335%2022.3097%205.61229%2022.3325C5.62123%2022.3553%205.63465%2022.376%205.65174%2022.3935C5.66883%2022.4111%205.68926%2022.425%205.71182%2022.4345C5.73437%2022.444%205.7586%2022.4489%205.78308%2022.4489H7.15868C7.25956%2022.4489%207.3398%2022.3686%207.3421%2022.2701C7.38795%2020.5001%208.09868%2018.8425%209.35506%2017.5861C10.655%2016.2862%2012.3814%2015.5709%2014.2201%2015.5709C16.0588%2015.5709%2017.7852%2016.2862%2019.0852%2017.5861C20.3415%2018.8425%2021.0523%2020.5001%2021.0981%2022.2701C21.1004%2022.3709%2021.1807%2022.4489%2021.2815%2022.4489H22.6571C22.6816%2022.4489%2022.7058%2022.444%2022.7284%2022.4345C22.751%2022.425%2022.7714%2022.4111%2022.7885%2022.3935C22.8056%2022.376%2022.819%2022.3553%2022.8279%2022.3325C22.8369%2022.3097%2022.8412%2022.2853%2022.8406%2022.2609C22.8176%2021.165%2022.5907%2020.0989%2022.1642%2019.0924ZM14.2201%2013.8284C13.1678%2013.8284%2012.1773%2013.418%2011.4322%2012.6729C10.6871%2011.9278%2010.2767%2010.9374%2010.2767%209.88504C10.2767%208.83271%2010.6871%207.84227%2011.4322%207.09715C12.1773%206.35204%2013.1678%205.94165%2014.2201%205.94165C15.2724%205.94165%2016.2629%206.35204%2017.008%207.09715C17.7531%207.84227%2018.1635%208.83271%2018.1635%209.88504C18.1635%2010.9374%2017.7531%2011.9278%2017.008%2012.6729C16.2629%2013.418%2015.2724%2013.8284%2014.2201%2013.8284Z'%20fill='%238590A2'/%3e%3c/g%3e%3c/svg%3e)
Co-authors
Following
Followers
Research Focus & Metrics
Explore full metrics on Scilit
Academic Career Length
25Years (2002-Present)
(Calculated once Scilit publication data is synced: current year − year of first publication + 1)
Representative Publications
View All Publications19 November 2009 in Experimental Dermatology
Journal Article
TTT. G. Tzellos
T. G. Tzellos
IKI. Klagas
I. Klagas
KVK. Vahtsevanos
K. Vahtsevanos
STS. Triaridis
S. Triaridis
Athanasia PrintzaEPE. Papakonstantinou
E. Papakonstantinou +3
1 March 2010 in Journal of Voice
Journal Article
MHMeropi E. Helidoni
Meropi E. Helidoni
TMThomas Murry
Thomas Murry
JMJoanna Moschandreas
Joanna Moschandreas
Christos LionisAthanasia PrintzaGVGeorge A. Velegrakis
George A. Velegrakis
23 May 2020 in European Archives of Oto-Rhino-Laryngology
Journal Article
Athanasia PrintzaJCJannis Constantinidis
Jannis Constantinidis
Purpose The sudden onset of smell and taste loss has been reported as a symptom related to COVID-19. There is urgent need to provide insight to the pandemic and evaluate anosmia as a potential screening symptom that might contribute to the decision to test suspected cases or guide quarantine instructions. Methods Systematic review of the PubMed/Medline, Cochrane databases and preprints up to May 3, 2020. Combined search terms included: “COVID-19”, “SARS-CoV-2”, “coronavirus”, “nose”, “anosmia”, “hyposmia”, “olfactory loss”, “smell loss”, “taste loss”, and “hypogeusia”. Results Our search identified 18 reviewed articles and 6 manuscript preprints, including a large epidemiological study, four observational case series, five case–controlled studies, five cross-sectional studies, five case series of anosmic patients and four electronic surveys. Great methodological differences were noted. A significant prevalence of anosmia is reported in COVID-19 patients. Controlled studies indicate that anosmia is more common in COVID-19 patients than in patients suffering from other viral infections or controls. Most of the studies reported either smell loss or smell plus taste loss. Less severe COVID-19 disease is related to a greater prevalence of anosmia. A quick recovery of the smell loss may be expected in most COVID-19 cases. Conclusion Anosmia is more prevalent in COVID-19 patients than in patients suffering from other respiratory infections or controls.
Journal Article
Athanasia Printza
Michael Katotomichelakis
Konstantinos ValsamidisSMSymeon Metallidis
Symeon MetallidisPPPeriklis Panagopoulos
Periklis PanagopoulosJCJannis Constantinidis
Jannis Constantinidis +2
A significant proportion of people infected with SARS-CoV-2 report a new onset of smell or taste loss. The duration of the chemosensory impairment and predictive factors of recovery are still unclear. We aimed to investigate the prevalence, temporal course and recovery predictors in patients who suffered from varying disease severity. Consecutive adult patients diagnosed to be infected with SARS-CoV-2 via reverse-transcription–polymerase chain reaction (RT-PCR) at two coronavirus disease-2019 (COVID-19) Reference Hospitals were contacted to complete a survey reporting chemosensory loss, severity, timing and duration, nasal symptoms, smoking, allergic rhinitis, chronic rhinosinusitis, comorbidities and COVID-19 severity. In a cross-sectional study, we contacted 182 patients and 150 responded. Excluding the critically ill patients, 38% reported gustatory and 41% olfactory impairment (74% severe/anosmia). Most of the patients (88%) recovered their sense of smell by two months (median: 11.5 days; IQR: 13.3). For 23%, the olfactory loss lasted longer than a month. There were no significant differences in the prevalence and duration of chemosensory loss between groups of varying COVID-19 severity, and sexes (all p > 0.05). Moderate hyposmia resolved quicker than more severe loss (p = 0.04). Smell and taste loss are highly prevalent in COVID-19. Most patients recover fast, but nearly one out of ten have not recovered in two months.
10 October 2011 in Otolaryngology–Head and Neck Surgery
Journal Article
Athanasia PrintzaAKAthanassios Kyrgidis
Athanassios Kyrgidis
EOEirini Oikonomidou
Eirini Oikonomidou
STStefanos Triaridis
Stefanos Triaridis
17 May 2018 in European Archives of Oto-Rhino-Laryngology
Journal Article
Athanasia PrintzaAKAthanasios Kyrgidis
Athanasios Kyrgidis
EPElena Pavlidou
Elena Pavlidou
STStefanos Triaridis
Stefanos Triaridis
JCJannis Constantinidis
Jannis Constantinidis
About Me
Professor of Otorhinolaryngology-Phoniatrics, School of Medicine, Aristotle University of Thessaloniki (AUTh), Greece, member of The European Academy of Sciences and Arts. EC, The Association of Medical Schools in Europe. Experts’ Panel, The DO'L Medical Educator Award, Oxford Centre of Medical Education, President, Hellenic Society of Phoniatrics and Swallowing disorders. Deputy President, School of Medicine Committee of International Relations. Fulbright Fellow at Stony Brook Medicine, SUNY. Medical Degree (AUTh), MSc in Medical Research (AUTh), MSc in Speech and Swallowing (University of Newcastle, UK), and PhD (AUTh). CPD in educational methodology and bioethics. Residency training in Greece and England, post-qualification training in England and Germany. Scholarships of excellence for undergraduate, MSc studies, PhD and postdoc research. Awards: excellence in International Teaching, International Recognition and Impact (AUTh), Thessaloniki Ambassador Award, Romanian ENT Society. Patient-centricity in Medical Education and Healthcare initiative in AUTh. Interdisciplinary teaching and research in outcome measures, medical education, patient-centered health care, shared decision-making, swallowing, voice, olfaction, digital health. A dedicated educator committed to fostering innovation, student and patient agency in learning and healthcare and enhancing societal accountability of medical education working to foster transformation of the healthcare and health education.